Is Neo Mercazole (Carbimazole) a steroid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Neo Mercazole a Steroid?

No, Neo Mercazole (carbimazole) is not a steroid—it is an antithyroid drug that inhibits thyroid hormone synthesis by blocking iodine organification in the thyroid gland. 1

Drug Classification and Mechanism

  • Carbimazole belongs to the mercaptoimidazoline class of antithyroid drugs, which are chemically and pharmacologically distinct from corticosteroids 1
  • The drug works by inhibiting iodine organification in the thyroid gland, thereby reducing thyroid hormone production and secretion 2
  • Carbimazole is a prodrug that is completely converted to methimazole (the active form) during absorption, with bioavailability of 80-95% 1

Clinical Context Where Confusion May Arise

The evidence shows that carbimazole and steroids are mentioned together in certain clinical scenarios, but they serve completely different purposes:

  • In immunotherapy-induced thyroid dysfunction, carbimazole is listed as a treatment option alongside steroids, but they are separate drug classes used for different indications—beta-blockers are first-line for symptomatic hyperthyroidism, while carbimazole is "rarely" required and steroids may be used for painful thyroiditis 3
  • Guidelines specifically distinguish between carbimazole (for anti-TSH receptor antibody-positive cases) and prednisolone (for painful thyroiditis), demonstrating they are different therapeutic agents 3

Pharmacological Properties Confirming Non-Steroid Classification

  • Carbimazole has a volume of distribution of approximately 40L and is virtually non-protein-bound, unlike steroids which typically have high protein binding 1
  • The drug has a half-life of 3-5 hours with total clearance of about 200ml/minute, pharmacokinetic properties inconsistent with steroid medications 1
  • Carbimazole concentrates specifically in the thyroid gland where it exerts its antithyroid effects, a mechanism completely different from steroid hormone receptor binding 1

References

Research

Clinical pharmacokinetics of antithyroid drugs.

Clinical pharmacokinetics, 1981

Research

[Pharmacology and dosage of thyrostatic drugs].

Acta medica Austriaca, 1987

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.